Article
Pharmaceutical Executive
Pedal to the Mettle
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Novartis’ Chronic Spontaneous Urticaria Treatment Rhapsido Receives FDA Approval
Pharmaceutical Executive Daily: September 29, 2025
Point of Care Lifts Reps Efforts
Pharmaceutical Executive Daily: September 26, 2025
Pharmaceutical Executive Daily: TrumpRx Revealed
FDA Grants Approval for Kedrion Biopharma’s Primary Humoral Immunodeficiency Treatment Qivigy